SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRAV.L Regulatory News (RAV)

  • There is currently no data for RAV

Director/PDMR Shareholding

10 Dec 2010 15:35

RNS Number : 7752X
Raven Russia Limited
10 December 2010
 



 

 

RAVEN RUSSIA LIMITED

 

("Raven Russia" or the "Company")

 

Director/PDMR Dealings

 

Pursuant to Disclosure and Transparency Rule 3.1.2 and AIM Rule 17 (Disclosure of Miscellaneous Information) the following information falls to be disclosed;

 

The Company was notified today, 10 December 2010, that Anton Bilton, Executive Deputy Chairman, purchased 226,000 Preference Shares in his own name and a further 56,000 Preference Shares in the name of the Bilton Family Discretionary Settlement of which he is a trustee, at a price of 123.5p. This transaction takes Anton Bilton's total interest in Preference Shares to 27,246,229 being 18.91% of the total Preference Shares in issue.

 

 

Enquiries

 

Raven Russia Limited Tel: + 44 (0) 1481 712955

Anton Bilton

Glyn Hirsch

 

Cardew Group Tel: + 44 (0) 207 930 0777

Tim Robertson

Catherine Maitland

 

Numis Securities Limited (NOMAD) Tel: + 44 (0) 207 7260 1000

Nick Westlake

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKKKDBPBDDFBD
Date   Source Headline
5th Jun 20207:00 amRNSNotice of AGM and Posting of Annual Report
28th May 20207:00 amRNSConvertible Preference Share Dividend (RAVC)
22nd May 20207:00 amRNSDisclosure of Rights Attached to Listed Securities
21st May 20207:00 amRNSScrip Dividend Circular (RAVP)
6th May 20207:00 amRNSPreference Share Dividend (RAVP)
23rd Apr 202012:45 pmRNSRe-Designation of Convertible Preference Shares
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSIssue of Preference Shares (RAVP)
17th Mar 20205:30 pmRNSDirector/PDMR Shareholding
16th Mar 20207:00 amRNSFinal Results
11th Mar 20204:30 pmRNSTransaction in Own Shares
27th Feb 20207:00 amRNSConvertible Preference Share Dividend (RAVC)
20th Feb 20207:00 amRNSScrip Dividend Circular (RAVP)
20th Feb 20207:00 amRNSScrip Dividend Circular (RAVP)
13th Feb 20206:00 pmRNSTransaction in Own Shares
6th Feb 20207:00 amRNSPreference Share Dividend (RAVP)
3rd Feb 20207:00 amRNSBlock Listing cancellation and six monthly return
2nd Jan 20207:00 amRNSTotal Voting Rights
31st Dec 201912:15 pmRNSDirector/PDMR Shareholding
30th Dec 20197:00 amRNSIssue of Preference Shares (RAVP)
12th Dec 201911:48 amRNSTransaction in Own Shares
11th Dec 20197:00 amRNSTransaction in Own Shares
10th Dec 20197:00 amRNSHolding(s) in Company
2nd Dec 20195:00 pmRNSTransaction in Own Shares
2nd Dec 201911:30 amRNSTransaction in Own Shares
28th Nov 20197:00 amRNSConvertible Preference Share Dividend (RAVC)
21st Nov 20193:00 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSScrip Dividend Circular (RAVP)
19th Nov 201912:00 pmRNSHolding(s) in Company
11th Nov 20197:00 amRNSTotal Voting Rights
8th Nov 20193:44 pmRNSResult of General Meeting and Tender Offer
7th Nov 20197:00 amRNSPreference Share Dividend (RAVP)
6th Nov 20193:00 pmRNSDirector/PDMR Shareholding
29th Oct 20194:30 pmRNSHolding(s) in Company
28th Oct 20197:00 amRNSAnnouncement of Tender Offer price in Rand
25th Oct 20194:50 pmRNSTransaction in Own Shares
17th Oct 20193:00 pmRNSDirector/PDMR Shareholding
9th Oct 20194:35 pmRNSPrice Monitoring Extension
9th Oct 20193:00 pmRNSTender Offer and Notice of GM
1st Oct 20197:00 amRNSTotal Voting Rights
27th Sep 20197:00 amRNSIssue of New Preference Shares (RAVP)
12th Sep 20196:00 pmRNSHolding(s) in Company
4th Sep 20196:00 pmRNSHolding(s) in Company
2nd Sep 20194:50 pmRNSDirector/PDMR Shareholding
2nd Sep 20197:00 amRNSTotal Voting Rights
29th Aug 20197:00 amRNSConvertible Preference Share Dividend (RAVC)
27th Aug 20197:00 amRNSHalf-year Report
23rd Aug 20199:00 amRNSHolding(s) in Company
22nd Aug 20197:00 amRNSScrip Dividend Circular (RAVP)
21st Aug 20194:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.